Warsaw reallocates drug production funds, provokes pharma industry criticism [Advocacy Lab Content]
The Polish government has reallocated €139.5 million from the National Recovery Plan to support the zero-emission economy. The move upset the Polish pharmaceutical sector as the funds were originally intended for drug production.